| 295 | 58 | 32 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:探讨短期氯吡格雷联合阿司匹林在治疗进展性缺血性脑卒中的临床疗效和安全性。方法:分析本院收治的90例进展性缺血性脑卒中患者的临床资料,根据治疗方法不同分为治疗组和对照组各45例,治疗组采用氯吡格雷联合阿司匹林治疗,对照组仅给予阿司匹林治疗,观察30d治疗变化,分别于治疗前及治疗后7、14、30d对患者进行美国国立卫生研究院卒中量表评分(NIHSS)、日常生活能力评分(ADL),以及治疗14、30dNIHSS和ADL绝对分值变化作为主要临床疗效判断标准,同时检测治疗前后血清高敏C反应蛋白(hs-CRP),动态复查颅脑CT和(或)MRI,观察有无颅内出血及消化系统不良反应。结果:治疗后7、14d治疗组NIHSS评分较对照组明显降低,治疗后30d时较对照组有更明显降低,差异具有统计学意义(P<0.05);治疗后30d时治疗组较对照组ADL评分有更明显降低,差异具有统计学意义(P<0.01);治疗后14、30d时,治疗组血清c-反应蛋白与对照组比较,差异具有统计学意义(P<0.05);两组均未出现明显药物不良反应,未发生致死性出血现象,差异无统计学意义(P>0.05)。结论:短期氯吡格雷联合阿司匹林治疗进展性缺血性脑卒中安全有效,能改善临床症状,降低血清hs-CRP水平,临床疗效氯吡格雷联合阿司匹林组比单用阿司匹林组显著。
Abstract：Objective:To analyze clinical efficacy and safety of short-term use of clopidogrel in combination with aspirin in the treatment of progressive ischemic stroke.Methods:A retrospective analysis was conducted in 90 patients hospitalized for progressive ischemic stroke.Ninety cases were divided into the treatment group(45cases)which were given the treatment of clopidogrel in combination with aspirin and the control group(45cases)was treated with aspirin only.The treatments lasted30-days in both groups.They were evaluated by NIHSS and ADL before the treatment,and at the 7th day,the 14 th day,the30 th day after the beginning of treatments.The changes of absolute scores of the NIHSS and ADL were regarded as the measurement of clinical efficacy.The hs-CRP and CT or MRI of the brain were checked.Results:The decrease of the NIHSS score and the level of hs-CRP and the increase of the ADL score of both groups were significant at the 7th day,the 14 th day,and the30 th day after the treatments.The differences of the NIHSS and ADL scores of the 7th day and the 14 th day between the two groups have statistical significance(P<0.05),the difference in ADL scores of the 30 th day was even more significant(P<0.01).Symptomatic intracranial hemorrhage and gastrointestinal adverse reaction didn't happen in neither of the two groups.The adverse event rates were similar between the two groups(P>0.05).Conclusion:Short-term use of clopidogrel in combination with aspirin in the treatment of progressive ischemic stroke is safe and can improve the clinical outcome and decrease the level of hs-CRP.The clinical efficacy is better than that of aspirin alone.
1 Vila N,Castillo J,Davalos A,et al.Proinflammatory cytokines and early neurological worsen in ischemic stroke[J].Stroke,2003,31(10):2325.
2 Davalos A,Toni D,Iweins F,et al.Neurological deterioration in acute ischemic stroke;potential predictors and associated factors in the Europe cooperative acute study(ECASS)[J].Stroke,1999,30(12);2631-2636.
3 Tei H,Uehiyama S,Ohara K,et al.Deteriorating ischemic stroke in 4clinical-categories classified by the Oxfordshire Community Stroke Project[J].Stroke,2000;31(9):2049-2054.
4 中华医学会神经科学会.各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379.
5 Thanvi B,Treadwell S,Robinson T.Early neurological deterioration in acute ischemic stroke:predictors,mechanisms and management[J].Postgrad Med J,2008,84(994):412-417.
6 Bang OY,Heo JH,Kim JY,et al.Middle cerebral artery stenosis is a major determinant in striatocapsular small deep infarction[J].Arch neural,2009,59(2):259-263.
7 Cola C,Clementi E,Biondi-Zoccai G,et al.From carotid plaque biology to serologic markers of vulnerability to predict the risk of cerebrovascular events[J].Acta Chir Belg,2007,107(2):129-142.
8 Formato M,Farina M,Spirito R,et al.Evidence for a proinflammatory and proteolytic environment in plaques from endarterectomy segments of human carotid arteries[J].Arterioscler Thromb Vasc Biol,2004,24(1):129-135.
9 Juan JB,Deepak LB,Jean-Marc H.Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients With atherothrombotic disease[J].Vasc Med,2007,12(2):113.
10 Sacco RL,Diener HC,Yusuf S,et al.Aspirin and extended releasee dipyridamole versus clopidogrel for recurrent stroke[J].N Engl J Med,2008,359(12):1238-1251.
11 顾晴,陈纪林.阿司匹林与氯吡格雷合用对兔动脉粥样硬化病变进展的抑制作用[J].中国医学科学院学报,2004,154(27):187-191.
12 Tataru MC,Heinrich J,Junker R,et al.C-reactive protein and the severity of atherosclerosis in myocardial in-faction patients with stable angina perish[J].Eur Heart J,2000,21(12):1000.
13 Johnson ES,Lanes SF,Wentworth CE,et al.A metaregression analysis of the dose-response effect of aspirin on stroke[J].Arch Intern Med.1999,159:1248-1253.
14 He J,Whelton PK,Vu B,et al.Aspirin and risk of hemorrhagic stroke:a Meta-analysis of randomized controlled trials[J].JAMA,1998;280:1930-1935.
15 Squizzato A,Keller T,Romualdi E.et al.Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease[J].Cochrane Database Syst Rev,2011,CD005158.
16 Hankey GJ,Johnston SC,Easton JD,et al.Effect of ciopidogrel plus ASA vs.ASA early after TIA and ischemic stroke:a substudy of the CHARISMA trial[J].Int J Stroke,2011,6(1):3-9.
17 Markus HS,Droste DW,Kaps M,et al.Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection:the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis(CARESS)trial[J].Circulation.2005,111:2233-2240.
18 Furie KL,Kasner SE,Adams RJ,et al.Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack:aguideline for healthcare professionals from the American heart association American stroke association[J].Stroke,2011,42:227-276.
19 Ringleb P,Bousser MG,Ford G.,et al.Guidelines for Management of Ischemic Stroke 2008.The European Stroke Organization(ESO)Executive Committee and the ESO Writing Committee[J].Cerebrovasc Dis,2008,25:457-507.
20 Anti-thrombotic Trialists'Collaboration.Collaborative Meta-analysis of randomized trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high risk patients[J].BMJ,2002;324:71-86.
21 Diener HC,Bogousslavsky J,Brass LM,et a1.Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke ortransient ischemic attack in high-risk patients(MATCH):randomized,double-blind,placebo-controlled trial[J].Lancet,2004,364(9431):331-337.
22 Wong KS,Chen C,Fu J.et al.Ciopidogrel plus aspirin versus aspirin alone for reducing embolization in patients with acute symptomatic cerebral or carotid artery stenosis(CLAIR study):a randomized open-label blinded-endpoint trial[J].Lancet Neurol,2010,9(5)489-497.
23 Kennedy J,Hill MD,Yckborst KJ,et al.Fast assessment of stroke and transient ischemic attack to prevent early recurrence(FASTER):a randomized controlled pilot trial[J].Lancet Neural,2007,(6)961-969.
24 Yong JW,Yi-long W,Xing-quan Z,et al.Clopidgrel with aspirin in acute minor stroke or transient ischemic attack[J].N Engr J Med,2013,369:11-19.
25 Phillips DR,Conley PB,Sinha U,et al.Therapeutic approaches in arterial thrombosis[J].Thrombi Haemostat,2005,3(12):1577-1589.
基本信息:
DOI：10.13210/j.cnki.jhmu.20140709.001
中图分类号:R743.3
引用信息:
[1]徐大飞,李凯,陈海波.氯吡格雷联合阿司匹林治疗进展性缺血性脑卒中的临床疗效和安全性[J].海南医学院学报,2014,20(09):1282-1285+1288.DOI:10.13210/j.cnki.jhmu.20140709.001.
2014-07-09
2014-07-09
2014-07-09